----
Current ValuationThe current P/E ratio is 14.10, within the reasonable range, cheaper than 57.85% of the time in the past 1 years, and the industry ranks 2/16, the industry Median 15.59.
14.1xP/E
HK$19.35Stock price
HK$1.37Earnings per share
14.1xP/E
Stock priceHK$19.35Earnings per shareHK$1.37
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 15.12x
- Typical range
- 13.03x–32.97x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 15.59x
013263952
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 15.59x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
06127HKJOINN | 15.59x | 176.51% | HK$17.67B |
03880HKMedtide Inc. | 14.10x | -- | HK$2.74B |
01873HKVIVA BIOTECH | 13.33x | -- | HK$2.73B |
06118HKAUSTAR | 15.98x | -- | HK$317.80M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
